I en kommentar/debatt-artikkel på Tidsskriftet for den norske legeforening, 14 mars 2016 sørget, ikke mindre enn to leger (overlege og forskningsdirektør) i fra spesialisthelsetjenestens avdeling for fysikalsk medisin og rehabilitering, avd Sunnaas sykehus HF, en lege (fagdirektør) og en psykolog i fra helsemyndighetenes mandatsrådgivende organ Nasjonalt Folkehelseinstitutt, en annen stakkars psykolog, gud Signe oss alle fra Norsk forening for Allmennmedisin’s MUPS avdeling og ja selvfølgelig ei ubetydlig velfødd ekstatisk Landmark, for nok en pinlig profosjonell forskningsmedisinsk akademisk forlegenhet. I denne spesielle «saken» er jeg for min del ikke helt sikker på hva som er mest kritikkverdig…
Dette er Oxford-kriterier og retningslinjer for forskningsstudier:
A report – chronic fatigue syndrome: guidelines for research
Sharpe, M.C. et al. .Journal of the Royal Society of Medicine Volume 84 February 1991
Report of a consensus meeting held Green College, Oxford 23 March 1990
The following guidelines were agreed.
A preliminary research glossary is appended. This comprises definitions for symptoms and suggestions for their description.
There are no clinical signs characteristic of the condition, but patients should be fully examined, and the presence or absence of signs reported.
Two broad syndromes can be defined:
Chronic fatigue syndrome (CFS)
(a) A syndrome characterized by fatigue as the principal symptom.
(b) A syndrome of definite onset that is not life long.
(c) The fatigue is severe, disabling, and affects physical and mental functioning.
(d) The symptom of fatigue should have been present for a minimum of 6 months during which it was present for more than 50% of the time.
(e) Other symptoms may be present, particularly myalgia, mood and sleep disturbance.
(f) Certain patients should be excluded from the definition. They include:
(i) Patients with established medical conditions known to produce chronic fatigue (eg severe anaemia). Such patients should be excluded whether the medical condition is diagnosed at presentation or only subsequently. All patients should have a history and physical examination performed by a competent physician.
(ii) Patients with a current diagnosis of schizophrenia, manic depressive illness, substance abuse, eating disorder or proven organic brain disease. Other psychiatric disorders (including depressive illness, anxiety disorders, and hyperventilation syndrome) are not necessarily reasons for exclusion.
Post-infectious fatigue syndrome (PIFS)
This is a subtype of CFS which either follows an infection or is associated with a current infection (although whether such associated infection is of aetiological significance is a topic for research).
To meet research criteria for PIFS patients must
(i) fulfil criteria for CFS as defined above, and
(ii) should also fulfil the following additional criteria:
(a) There is definite evidence of infection at onset or presentation (a patient’s self-report is unlikely to be sufficiently reliable).
(b) The syndrome is present for a minimum of 6 months after onset of infection.
(c) The infection has been corroborated by laboratory evidence.
In reporting studies it should be clearly stated which of these two syndromes is being studied. The degree of disability should be measured and stated. The criteria and method used to exclude subjects from study must be clearly described and the degree of examination and investigation specified. All patients should be assessed for associated psychiatric disorder and the results of this assessment reported.
Les videre: Kreyberg, S.E. (2004). Pasienter ut av ingenmannsland: Registeret for myalgisk encefalopati – ME/post viralt fatigue syndrom – PVFS. Norsk Epidemiologi 2004; 14 (1): 79-83.
Les mer «Dagen da Norske Helsemyndigheter ønsket «Lightning Process» systematisk brukt i helsetjenesten…»